Omalizumab facilitates rapid oral desensitization for peanut allergy

Peanut oral immunotherapy is a promising approach to peanut allergy, but reactions are frequent, and some patients cannot be desensitized. The anti-IgE medication omalizumab (Xolair; Genentech, South San Francisco, Calif) might allow more rapid peanut updosing and decrease reactions. We sought to ev...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of allergy and clinical immunology Ročník 139; číslo 3; s. 873 - 881.e8
Hlavní autori:	MacGinnitie, Andrew J., Rachid, Rima, Gragg, Hana, Little, Sara V., Lakin, Paul, Cianferoni, Antonella, Heimall, Jennifer, Makhija, Melanie, Robison, Rachel, Chinthrajah, R. Sharon, Lee, John, Lebovidge, Jennifer, Dominguez, Tina, Rooney, Courtney, Lewis, Megan Ott, Koss, Jennifer, Burke-Roberts, Elizabeth, Chin, Kimberly, Logvinenko, Tanya, Pongracic, Jacqueline A., Umetsu, Dale T., Spergel, Jonathan, Nadeau, Kari C., Schneider, Lynda C.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States Elsevier Inc 01.03.2017 Elsevier Limited
Predmet:	Adolescent Adult Allergens - immunology Allergy and Immunology Anti-Allergic Agents - therapeutic use Arachis - immunology Arachis hypogaea Child desensitization Desensitization, Immunologic Double-Blind Method Drug dosages Female Food Food allergies food allergy Humans Immunoglobulin E - blood Immunotherapy Male omalizumab Omalizumab - therapeutic use Peanut allergy Peanut Hypersensitivity - drug therapy Peanut Hypersensitivity - therapy Peanuts Proteins Skin Tests Studies Young Adult Peanut allergy SPT ITT omalizumab EoE OIT food allergy desensitization DBPCFC Double-blind, placebo-controlled food challenge Eosinophilic esophagitis Skin prick test Oral immunotherapy Intention to treat
ISSN:	0091-6749, 1097-6825, 1097-6825
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!